Schivo announces strategic recapitalisation from Five Arrows as MML exits
Schivo, the leading global player in outsourced contract development and manufacturing for healthcare OEMs primarily in the medical device and life sciences spaces, is delighted to announce a new investment by Five Arrows, the alternative assets arm of Rothschild & Co. This transaction allows MML Growth Capital Partners Ireland to successfully exit our minority position in the company.
We use cookies on this website to collect data for analytics purposes. This allows us to understand how our website is being used so we can create the best experience for you. For further details on our use of cookies, please see our Privacy Policy and Cookies Policy. If you are happy for us to use these cookies, please click “Accept”. If not, please click “Reject”.
You can revoke your consent any time using the revoke consent button.